NBPF25P

Across TCGA pan-cancer cohorts, NBPF25P Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated NBPF25P data layer compared with 26 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher NBPF25P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NBPF25P expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCEC show a favorable association.

BRCA, THYM, and BLCA are the cancer types where NBPF25P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.335	0.924	<.001	36	view →
THYM	OS	Median	All	0.039	0.928	<.001	24	view →
BLCA	DFS	Median	All	0.511	0.344	.031	10	view →
UCEC	DFS	Median	All	1.000	0.630	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NBPF25P–BRCA (OS)

Open the BRCA breakdown →